165 related articles for article (PubMed ID: 32126201)
1. Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis.
Luo J; Wu Z; Lu Y; Xiong K; Wen Q; Zhao L; Wang B; Gui Y; Fu S
Int J Biol Macromol; 2020 Jun; 152():718-726. PubMed ID: 32126201
[TBL] [Abstract][Full Text] [Related]
2. Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis.
Yun Q; Wang SS; Xu S; Yang JP; Fan J; Yang LL; Chen Y; Fu SZ; Wu JB
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27762505
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.
Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z
Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210
[TBL] [Abstract][Full Text] [Related]
4. 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.
Wang Y; Gong C; Yang L; Wu Q; Shi S; Shi H; Qian Z; Wei Y
BMC Cancer; 2010 Aug; 10():402. PubMed ID: 20678220
[TBL] [Abstract][Full Text] [Related]
5. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis.
Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H
Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379
[TBL] [Abstract][Full Text] [Related]
6. Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel.
Liu L; Wu Q; Ma X; Xiong D; Gong C; Qian Z; Zhao X; Wei Y
Colloids Surf B Biointerfaces; 2013 Jun; 106():93-101. PubMed ID: 23434697
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer.
Emoto S; Yamaguchi H; Kamei T; Ishigami H; Suhara T; Suzuki Y; Ito T; Kitayama J; Watanabe T
Surg Today; 2014 May; 44(5):919-26. PubMed ID: 23887848
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
[TBL] [Abstract][Full Text] [Related]
9. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
10. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
[TBL] [Abstract][Full Text] [Related]
11. The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model.
Yu J; Lee HJ; Hur K; Kwak MK; Han TS; Kim WH; Song SC; Yanagihara K; Yang HK
Invest New Drugs; 2012 Feb; 30(1):1-7. PubMed ID: 20669041
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
13. Injectable biodegradable hydrogels from vitamin D-functionalized polycarbonates for the delivery of avastin with enhanced therapeutic efficiency against metastatic colorectal cancer.
Lee AL; Ng VW; Gao S; Hedrick JL; Yang YY
Biomacromolecules; 2015 Feb; 16(2):465-75. PubMed ID: 25543531
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion.
Chen CH; Kuo CY; Chen SH; Mao SH; Chang CY; Shalumon KT; Chen JP
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734717
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer.
Fan R; Tong A; Li X; Gao X; Mei L; Zhou L; Zhang X; You C; Guo G
Int J Nanomedicine; 2015; 10():7291-305. PubMed ID: 26664119
[TBL] [Abstract][Full Text] [Related]
16. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis.
Gong Q; Song C; Wang X; Wang R; Cai G; Liang X; Liu J
Exp Biol Med (Maywood); 2020 Mar; 245(6):542-551. PubMed ID: 32041417
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules.
Yamashita K; Tsunoda S; Gunji S; Murakami T; Suzuki T; Tabata Y; Sakai Y
Surg Today; 2019 Sep; 49(9):785-794. PubMed ID: 30847629
[TBL] [Abstract][Full Text] [Related]
19. Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial.
Murono K; Nagata H; Ishimaru K; Emoto S; Kaneko M; Hiyoshi M; Sasaki K; Otani K; Shuno Y; Nishikawa T; Tanaka T; Hata K; Kawai K; Nozawa H; Muro K; Ishihara S
Cancer Chemother Pharmacol; 2019 Jan; 83(1):145-150. PubMed ID: 30386886
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
